Contemporary psychosocial care in the CFTR modulator era – A LWWCF training program for CF multidisciplinary teams
Pre-training sign-in and survey
Please note: the LWWCF Training Program for CF MDTs is for Australian and New Zealand health professionals only.
NZ healthcare professionals need to be aware of the significant differences between Australia and New Zealand in terms of cystic fibrosis medication registration, availability and funding status. Please refer to the Medsafe and Pharmac websites for further information.
The LWWCF CF MDT Training workshop is a medical education event sponsored by Vertex Pharmaceuticals (Australia) Pty Ltd and is for Australian and New Zealand healthcare professionals only. All content is developed by the scientific committee, chairs and speakers for the meeting, with support from a medical education agency acting as secretariat. The company has had an opportunity to review the materials for scientific accuracy and fair balance. The views expressed are based on the experience of the speakers and not Vertex. This educational event is targeted at your professional development. There is no charge for attending this event. All attendance at Vertex-sponsored events is documented.
The Vertex and Vertex triangle logo are registered trademarks of Vertex Pharmaceuticals Incorporated. Australia: Vertex Pharmaceuticals (Australia) Pty Ltd. Level 3, 601 Pacific Highway, St Leonards, NSW 2065 Australia. ABN 34 160 157 157. Vertex Medical Information contact: 1800 179 987 (AU). New Zealand: Pharmacy Retailing (NZ) t/a Healthcare Logistics, P.O. Box 62027 Sylvia Park, Auckland 1644. Telephone: 0508 553 435 or email email@example.com. © 2023 Vertex Pharmaceuticals Incorporated. AU-20-2300119. Date of Approval: October 2023. TAPS NP19697.